• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的新型双嵌入蒽环类抗生素设计。

Structure-based design of a new bisintercalating anthracycline antibiotic.

作者信息

Chaires J B, Leng F, Przewloka T, Fokt I, Ling Y H, Perez-Soler R, Priebe W

机构信息

Department of Biochemistry, University of Mississippi Medical Center, Jackson 39216-4505, USA.

出版信息

J Med Chem. 1997 Jan 31;40(3):261-6. doi: 10.1021/jm9607414.

DOI:10.1021/jm9607414
PMID:9022792
Abstract

A new bisintercalating anthracycline antibiotic, WP631, has been designed and synthesized. The rational design of the new compound was based upon the geometry of monomeric anthracyclines bound to DNA oligonucleotides observed in high-resolution crystal structures. Monomeric units of daunorubicin have been linked through their reactive 3' NH2 substituents on the daunosamine moieties to form the new bisanthracycline WP631. Viscosity studies confirmed that WP631 binds to DNA by bisintercalation. Differential scanning calorimetry and UV melting experiments were used to measure the ultratight binding of WP631 to DNA. The binding constant for the interaction of WP631 with herring sperm DNA was determined to be 2.7 x 10(11) M-1 at 20 degrees C. The large, favorable binding free energy of -15.3 kcal mol-1 was found to result from a large, negative enthalpic contribution of -30.2 kcal mol-1. A molecular model was generated that shows the favorable stereochemical fit of the linker in the DNA minor groove. The cytotoxicity of WP631 was compared to that of doxorubicin using MCF-7-sensitive and MCF-7/VP-16 MRP-mediated multidrug-resistant cell lines. These initial studies showed that while WP631 is slightly less cytotoxic than doxorubicin in the sensitive cell line, it appears to overcome MRP-mediated multidrug resistance and was much more cytotoxic against the MCF-7/VP-16 cell line than was doxorubicin. The design of new potential anticancer agents based on known structural principles was found to produce a compound with significantly increased DNA binding affinity and with interesting biological activity.

摘要

一种新型双插入蒽环类抗生素WP631已被设计并合成。该新型化合物的合理设计基于在高分辨率晶体结构中观察到的与DNA寡核苷酸结合的单体蒽环类药物的几何结构。柔红霉素的单体单元通过其柔红糖胺部分上具有反应活性的3' NH2取代基连接在一起,形成了新型双蒽环类药物WP631。黏度研究证实WP631通过双插入作用与DNA结合。差示扫描量热法和紫外熔解实验被用于测定WP631与DNA的超紧密结合。在20℃下,WP631与鲱鱼精DNA相互作用的结合常数被测定为2.7×10(11) M-1。发现-15.3 kcal mol-1的大的、有利的结合自由能是由-30.2 kcal mol-1的大的负焓贡献导致的。生成了一个分子模型,该模型显示了连接体在DNA小沟中的良好立体化学契合。使用MCF-7敏感细胞系和MCF-7/VP-16 MRP介导的多药耐药细胞系,将WP631的细胞毒性与阿霉素的细胞毒性进行了比较。这些初步研究表明,虽然WP631在敏感细胞系中的细胞毒性略低于阿霉素,但它似乎能克服MRP介导的多药耐药性,并且对MCF-7/VP-16细胞系的细胞毒性比阿霉素大得多。基于已知结构原理设计新的潜在抗癌药物,结果产生了一种DNA结合亲和力显著增加且具有有趣生物活性的化合物。

相似文献

1
Structure-based design of a new bisintercalating anthracycline antibiotic.基于结构的新型双嵌入蒽环类抗生素设计。
J Med Chem. 1997 Jan 31;40(3):261-6. doi: 10.1021/jm9607414.
2
Ultratight DNA binding of a new bisintercalating anthracycline antibiotic.一种新型双插入蒽环类抗生素与DNA的超紧密结合
Biochemistry. 1998 Feb 17;37(7):1743-53. doi: 10.1021/bi9720742.
3
A new bisintercalating anthracycline with picomolar DNA binding affinity.一种具有皮摩尔级DNA结合亲和力的新型双嵌入蒽环类药物。
J Med Chem. 2005 Dec 29;48(26):8209-19. doi: 10.1021/jm050902g.
4
Binding of two novel bisdaunorubicins to DNA studied by NMR spectroscopy.通过核磁共振光谱法研究两种新型双柔红霉素与DNA的结合。
Biochemistry. 1997 Jul 22;36(29):8663-70. doi: 10.1021/bi970842j.
5
Structure of a DNA-bisdaunomycin complex.一种DNA-双去甲氧基柔红霉素复合物的结构。
Biochemistry. 1997 May 20;36(20):5940-6. doi: 10.1021/bi9705218.
6
Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.蒽环类药物结构修饰对克服癌细胞耐药性能力的影响。
Anticancer Res. 2006 May-Jun;26(3A):2009-12.
7
Exploiting anthracycline scaffold for designing DNA-targeting agents.利用蒽环类药物骨架设计DNA靶向剂。
Methods Enzymol. 2001;340:529-55. doi: 10.1016/s0076-6879(01)40441-1.
8
Parsing the free energy of anthracycline antibiotic binding to DNA.解析蒽环类抗生素与DNA结合的自由能。
Biochemistry. 1996 Feb 20;35(7):2047-53. doi: 10.1021/bi952812r.
9
Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.抗肿瘤剂。3. 具有强细胞毒性活性的新型吡啶并异喹啉二酮和二氢噻吩并喹啉二酮衍生物的设计、合成及生物学评价。
J Med Chem. 2004 Feb 12;47(4):849-58. doi: 10.1021/jm030918b.
10
Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.表柔比星多聚甲醛:一种水解稳定性更高、对耐药肿瘤细胞有毒性的蒽环类-甲醛共轭物
J Med Chem. 1998 Apr 9;41(8):1306-14. doi: 10.1021/jm970739s.

引用本文的文献

1
Novel and Structurally Diversified Bacterial DNA Gyrase Inhibitors Discovered through a Fluorescence-Based High-Throughput Screening Assay.通过基于荧光的高通量筛选测定法发现的新型且结构多样的细菌DNA促旋酶抑制剂。
ACS Pharmacol Transl Sci. 2022 Sep 2;5(10):932-944. doi: 10.1021/acsptsci.2c00113. eCollection 2022 Oct 14.
2
Design and synthesis of hybrid compounds as novel drugs and medicines.作为新型药物的杂化化合物的设计与合成。
RSC Adv. 2022 Jul 6;12(30):19470-19484. doi: 10.1039/d2ra03281c. eCollection 2022 Jun 29.
3
Novel Homo-Bivalent and Polyvalent Compounds Based on Ligustrazine and Heterocyclic Ring as Anticancer Agents.
基于川芎嗪和杂环的新型同双价和多价化合物作为抗癌剂。
Molecules. 2019 Dec 9;24(24):4505. doi: 10.3390/molecules24244505.
4
Synthesis, Biological Activity and Preliminary in Silico ADMET Screening of Polyamine Conjugates with Bicyclic Systems.含双环体系的多胺共轭物的合成、生物活性及计算机辅助ADMET初步筛选
Molecules. 2017 May 12;22(5):794. doi: 10.3390/molecules22050794.
5
DNA Interaction Studies of Selected Polyamine Conjugates.所选多胺共轭物的DNA相互作用研究
Int J Mol Sci. 2016 Sep 19;17(9):1560. doi: 10.3390/ijms17091560.
6
Two drugs are better than one. A short history of combined therapy of ovarian cancer.两种药物优于一种。卵巢癌联合治疗简史。
Contemp Oncol (Pozn). 2015;19(5):350-3. doi: 10.5114/wo.2014.43975. Epub 2014 Jul 15.
7
Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells.自噬调节双蒽环类药物WP631对p53基因缺陷型前列腺癌细胞的作用。
J Cell Mol Med. 2015 Apr;19(4):786-98. doi: 10.1111/jcmm.12402. Epub 2015 Feb 16.
8
Design, synthesis and DNA interaction study of new potential DNA bis-intercalators based on glucuronic acid.基于葡萄糖醛酸的新型潜在 DNA 双嵌入剂的设计、合成与 DNA 相互作用研究。
Int J Mol Sci. 2013 Aug 15;14(8):16851-65. doi: 10.3390/ijms140816851.
9
A new bisintercalating anthracycline with picomolar DNA binding affinity.一种具有皮摩尔级DNA结合亲和力的新型双嵌入蒽环类药物。
J Med Chem. 2005 Dec 29;48(26):8209-19. doi: 10.1021/jm050902g.
10
Cooperative effects on the formation of intercalation sites.对嵌入位点形成的协同效应。
Nucleic Acids Res. 2004 Sep 1;32(15):4696-703. doi: 10.1093/nar/gkh788. Print 2004.